Back

Protease inhibitors and risk for heart failure among patients with human immunodeficiency virus infection

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart failure is a complex syndrome: look at comorbidities Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Robin Jacob

Stony Brook University Hospital, Stony Brook (United States of America)

4 More presentations in this session

Presentation thumbnail
Moderate alcohol consumption is associated with progression of left ventricular dysfunction in a European stage B heart failure population.
Doctor B. Wong (Dublin, IE)
Abstract Slides
Presentation thumbnail
Long-term risk of mortality and heart failure hospitalization in patients with heart failure with and without autoimmune disease
Ms G. Sun (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Chronic heart failure in real-world setting: fitting the patient into the profile
Mr S. Radhoe (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Impact of diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes.
Professor L. Fauchier (Tours, FR)
Abstract Slides

Access the full session

Session thumbnail
Heart failure is a complex syndrome: look at comorbidities

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Rare causes of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources